Lenome 10mg Lenalidomide Price USA | Ernest Oncology Indian Exporter

Lenome 10mg Capsule: Advanced Immunomodulatory Therapy for Multiple Myeloma and MDS

Are you searching for a reliable Lenome 10 mg capsule exporter from India? Ernest Oncology, a flagship division of Ernest Pharmaceutical Pvt. Ltd., is a globally recognized supplier and bulk distributor of high-quality oncology therapeutics. We specialize in the international distribution of critical hematology medications to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring seamless logistics and pharmaceutical-grade handling for global oncology centers.

Detailed Product Overview: What is Lenome 10mg?

Lenome 10mg is a potent oral antineoplastic agent containing the active pharmaceutical ingredient Lenalidomide. It belongs to the Immunomodulatory Imide (IMiD) class of drugs. Developed to target the underlying biological mechanisms of blood-related malignancies, Lenome 10mg is a highly refined derivative of thalidomide, engineered to deliver maximum therapeutic efficacy with a manageable side-effect profile.

The 10mg strength is strategically essential in oncology, primarily used for:

• Maintenance Therapy: Sustaining remission in patients after stem cell transplantation.

• Titrated Dosing: Ideal for patients requiring dosage adjustments due to renal sensitivity or age-related factors.

• Combination Protocols: Often paired with dexamethasone or bortezomib for a multi-targeted attack on cancer cells.

Primary Therapeutic Indications:

Lenome 10 mg is clinically indicated for the management of:

• Multiple Myeloma (MM): For adult patients who are newly diagnosed or have received at least one prior therapy.

• Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia caused by low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

• Mantle Cell Lymphoma (MCL): For patients whose disease has progressed or relapsed after two prior therapies.

• Follicular Lymphoma (FL): In combination with rituximab for previously treated patients.

Mechanism of Action: How Lenome 10mg Combats Cancer: 

Lenome 10mg works through a comprehensive, multi-modal biological process:

1. Selective Tumor Apoptosis: It binds to the cereblon E3 ubiquitin ligase complex, leading to the degradation of transcription factors Aiolos and Ikaros. This results in direct programmed cell death in malignant B-cells.

2. Anti-Angiogenesis: It prevents the formation of new blood vessels in the bone marrow, effectively "starving" the tumor of the nutrients required to grow.

3. Enhanced Immunosurveillance: It activates Natural Killer (NK) cells and T-lymphocytes, empowering the body's innate immune system to identify and destroy "stealthy" cancer cells.

4. Cytokine Inhibition: It blocks the production of pro-inflammatory cytokines like TNF-α and IL-6, which are known to fuel the growth of myeloma cells.

Clinical Administration & Safety: 

• Dosage Schedule: Typically administered in 21-day or 28-day cycles. Consistency in timing is key.

• Instruction: Capsules must be swallowed whole with water. Do not break, open, or chew the capsules.

• Safety Warning: Embryo-Fetal Toxicity. Lenome 10mg can cause severe, life-threatening birth defects. Stringent REMS protocols must be followed.

• Side Effect Monitoring: Clinical staff should monitor for neutropenia, thrombocytopenia, and blood clots.

Why Source Lenome 10 mg from Ernest Oncology?

• Direct Exporter from India: We offer factory-direct procurement from GMP-certified facilities, guaranteeing 100% authenticity.

• Global B2B Supply Chain: We manage large-scale bulk orders for hospitals and clinics across the USA, UK, UAE, Australia, and South Africa. 

• Cold-Chain Excellence: Our logistics team ensures that sensitive medications are shipped under validated conditions.

• Regulatory Compliance: We provide all necessary documentation, including COAs and export permits.